ABSTRACT Vigabatrin (7-vinyl GABA), an enzyme-activated, irreversible inhibitor of GABA transaminase, was administered orally to albino Sprague Dawley and pigmented Lister-Hooded rats. A dose-dependent retinal lesion characterized histologically by disruption of the outer nuclear layer was observed in the Sprague Dawley rat but not in Lister-Hooded rats, indicating that this alteration is related to the absence of pigment. The lesion is similar to that induced in albino rats by light and certain drugs. In addition, myelin vacuolation of the brain was observed in both rat strains, consistent with the findings of other toxicity studies with vigabatrin. In all cases, the vacuolation was limited to myelinated tracts and resulted from separation of the myelin sheath at the intraperiod line. There was no evidence of demyelination, axonal degeneration or damage to contiguouS structures in the affected areas. The vacuolation is histologically similar to that induced in rats by certain other compounds such as isoniazid, hexachlorophene, and triethyltin, but differs in that it is focal in distribution, it is limited to the brain, and is reversible upon cessation of treatment.
INTRODUCTION
Vigabatrin (7-vinyl GABA), a specific enzymeactivated, irreversible inhibitor of GABA transaminase, has been developed as an anti-epileptic drug by the Merrell Dow Research Institute. It has been postulated that the neurochemical abnormality in .epilepsy is an impairment of inhibitory transmission involving gamma aminobutyric acid (GABA) in the brain, the levels of which are raised by treatment with vigabatrin (6) .
In preclinical toxicity studies, microvacuolation of white matter in the brain of the mouse, rat and dog was noted (5, 9, 10, 15), although no illustrations of the lesions were presented. Studies in the monkey gave equivocal results. I n addition to these observations, incomplete studies in the Sprague Dawley albino rat have suggested a retinopathy not previously observed.
The present study was undertaken to investigate the reproducibility of the retinal lesion and to further investigate the intramyelinic edema. Preliminary histological examination of the retinal effect showed some similarities to the changes produced by light in albino rats (4, 8, 12) . Therefore, to investigate the possibility that the changes were related to absence of pigment, a pigmented rat was also given the drug at a level which would be expected to produce microvacuolation of the white matter, and also provide indirect evidence of systemic absorption.
Test Article. Vigabatrin (4-amino-hex-5-enoic acid) was supplied by the Merrell Dow Research Institute. It was stored in a covered plastic container at approximately 4"C, except when removing aliquots for the preparation of dosing solutions or diets.
Aninrals. Weanling male rats were obtained from specified-pathogen-free colonies. The Sprague Dawley derived strain was obtained from Charles River U.K. Ltd., Margate, Kent; the Lister-Hooded strain from Olac 1976 Ltd., Bicester, Oxfordshire. The animals were housed, 3 per cage, in plastic and stainless-steel grid floored cages and acclimatized to the study conditions for 10 days prior to treatment. They were allowed free access to a nutritionally adequate diet (R & M No. 1 (modified) expanded ground, Special Diet Services Ltd., Witham, Essex) and tap water, which was measured-for each cage twice each week and divided by the number of rats per cage. Standard environmental conditions were used which 143 TOXICOLOGIC PATHOLOGY included 12-hour lighvdark cycles. Mean light intensity outside the cage was 260 lux; inside, 24 fc.
Experinierital. Fifteen rats were assigned to each of 12 groups. Two groups of Sprague Dawley and 2 groups of Lister-Hooded rats were controls for the gavage and diet administration. Groups of Sprague Dawley rats received 30, 100 and 300 mg/kg per day by gavage and diet. Groups of Lister-Hooded rats received 300 mg/kg by gavage and diet.
For treatment by gavage, a 3% solution of vigabatrin was prepared by dissolving the test article in distilled water. Aliquots of this solution were diluted to 1.0 and 0.3%. The solutions were administered to the animals at a volume of 10 mVkg body weight by oral intubation using rubber catheters attached to glass-barreled syringes. The animals were dosed daily throughout the study with the fresh solutions prepared each day, For administration in the diet, weighed amounts of vigabatrin were blended with weighed basal diet in a mechanical mixer to produce the diets for the 300 mg/kg groups. Diets for the 30 and 100 mg/kg groups were made by diluting aliquots from one of these mixtures with additional basal diet. The control and gavage groups were fed the basal diet without vigabatrin.
On days 4 and 86 of the study each animal was subjected to an ophthalmic examination. The pupil ofone eye ofeach rat was diluted with 1% Mydriacyl preparation to aid this examination. Prior to killing at the end of the treatment period, the rats were deprived of food overnight, with water available.
With the exception oftwo Sprague Dawley rats from the 300 mg/kg gavage group, which were selected for electron microscopy preparations, the animals were killed by COz exposure and the brain and both eyes were removed. The brains were fixed and preserved in 10% neutral buffered formalin. The eyes were fixed in Davidson's solution (40% formaldehyde, 20 ml; glacial acetic acid, 10 ml; ABS alcohol, 30 ml; water, 4 ml), and double-embedded in celloididparaffin wax.
The two 300 mg/kg gavage-group Sprague Dawley rats selected for electron microscopy preparation were perfused with Karnovsky's fluid under ether anesthesia. After perfusion, the eyes were removed immediately and fixed in Davidson's solution; the brains were left in sitti for 3 hours.
Wax-embedded 5 pm sections of the eyes and of cortex, cerebellum and medulla were stained with hematoxylin and eosin. Sections of eye from all the animals in the study were examined in random order without prior knowledge of treatment group.
The brains from both rats perfused for electron microscopy were post-fixed in 2% osmium tetroxide, embedded in epodaraldite, sectioned at 1 pm, and stained with toluidine blue. Ultrathin sections of selected areas were cut on an OMU3 ultratome, stained with uranyl acetate and lead citrate, and examined in a Jeol 100 electron microscope. RESULTS In general, examination of the animals from both strains during the study showed only minor variations in condition, none of which persisted. Toward the end of the treatment period, however, three Sprague Dawley rats in the higher dose groups were observed to have convulsions in response to stimuli such as noise or sudden movement. These convulsions consisted of a period of violent contortions, sometimes followed by a period of catatonia. Only two Lister-Hooded rats were observed to convulse, both from the 300 mg/kg/day gavage group.
The body weight values showed reduced weight gain by all the treated animals in both the gavage and dietary' groups. For example, in the 300 mg/kg Sprague Dawley dietary and gavage groups, weight gains as percent of control values were 48 and 59 percent, respectively; for the Lister-Hooded, these values were 72 and 70 percent. Statistically significant differences in body weights, compared with the controls, were apparent at all levels, with the exception of the 30 mg/kg/day Sprague Dawley group. Food intake was reduced in a similar pattern, but was more pronounced in the groups given vigabatrin by the dietary route. The average intakes for the study were, for the Sprague Dawley 30, 100 and 300 mg/kg dose groups, 26,99 and 304 mg/kg/ day, respectively, and for the Lister-Hooded 300 mg/kg group, 304 mg/kg/day. The ophthalmic examination at weeks 1 and 13 did not reveal any unusual or dose-related effects.
For each rat, sections from both eyes were ex- amined without knowledge of treatment group; a summary of the incidence of retinal changes observed is given in Table I . The changes present consisted of a disorganization of the outer nuclear layer with displacement of the nuclei into the rod layer. There was no definite evidence of necrosis, although there appeared to be fewer nuclei per unit area. No inflammatory infiltrate was present and no other layer of the retina was affected. The lesion appeared to be distributed more to the periphery of the eye. The effect compared to the control (Fig. 1) was graded as mild (Fig. 2) , moderate or marked (Fig. 3) according to the proportion of the retina affected. No lesions were observed in the Lister-Hooded rats (Fig. 4) . The lesions in the Sprague Dawley strain showed a dose response of both incidence and severity; the gavage-treated animals appeared to exhibit more marked lesions. No lesions were observed at 30 mg/kg in the dietary groups, and in the gavage groups only a single rat at the 30 mg/kg level was affected. This individual had an extensive lesion comparable to the most severe in the high dose group. In all cases the optic nerves, where present in the sections examined, were normal.
The brains were examined at three levels-cortex including hippocampus and thalamus, cerebellum and pons, and medulla. The most common lesion observed was edema of the white matter of the cerebellum, usually adjacent to the roof nuclei (Fig. 5) . The incidence and severity of the cerebellar lesion, shown in Table 11 , was similar, in both strains, but some cases hippocampal vacuolation was present (Fig. 6 ). The hippocampal lesion was less marked in the Lister-Hooded rats, and in the Sprague Dawley rat was greater in the 30 and 100 mg/kg groups than in the 300 mg/kg group. the Lister-Hooded rats showed less severe effects. In the more severely affected animals the edema was also found in the folia of the cerebellum, pons, thalamic tracts, optic tracts and internal capsule. In uranium. x 5,600.
Brain sections from six treated Sprague Dawley rats which exhibited the lesion and two untreated controls were stained to demonstrate myelin. The results of this technique showed that the vacuolation of the white matter was caused by myelin separation, and there was no evidence of demyelination.
Electron microscopic examination of brain sections from Sprague Dawley rats given 300 mg/kg/ day of vigabatrin by gavage confirmed that the white matter edema was the result of separation of the outer lamellae of the myelin sheath along the intraperiod line (Fig. 7) . The only evidence of myelin change was occasional localized areas of disruption (Fig. 8) . The axons within a myelin sheath showi,ng these changes and the neuronal cell bodies were normal (Fig. 9) . The neuropil, consisting of dendritic processes, unmyelinated fibers and glial fibers, was normal (Fig. 10) . Neuronal and oligodendrogial cell bodies were normal and there was no increase in the extracellular space.
DISCUSSION
The present study has confirmed that in albino rats, but not in a strain of pigmented rats, a retinopathy may be related to the administration of vigabatrin. The histological changes in the albino, which were not observed on ophthalmological examination, were characterized by disruption of the outer nuclear layer with displacement of the nuclei into the rod layer. The other layers of the retina were not affected.
The histological features of this lesion are similar to those reported in albino rats following excessive exposure to light (4, 8, 12) , and have also been reported following treatment with drugs such as clonidine (14) . However, light exposure was also essential in those animals receiving clonidine, as suturing the lid of one eye, but not the other, prevented the development of retinal lesions in the sutured eye.
In the present study, the pigmented Lister-Hooded rat failed to develop the lesion, indicating that this alteration may be dependent upon the absence of pigment. These observations are consistent with those noted in other pigmented species (1 5). Apart from the slightly greater incidence in the gavagetreated Sprague Dawley rats (Table I ), the retinal lesion was similar in both the dietary and gavage groups. Administration by gavage can be expected to produce transitory higher blood levels of the compound, which may be the cause of the different degree of reaction. The no effect level for eye changes is 30 mg/kg/day by the dietary route; at this level in the gavaged animals only a single rat exhibited the lesion. This animal had an extensive lesion comparable to the most severe effect at the highest dose and appeared to be anomalous. It is of interest that in preclinical toxicity studies in the rat, undertaken for the clinical development of vigabatrin, this retinal lesion was not present, although the dose levels were similar (15) . It is possible that this difference reflects the variation in caging and light intensities of animal rooms in the different laboratories.
Vacuolation of the white matter has been a consistent feature of preclinical toxicity studies in the rat, mouse and dog (5, 10, 15) . Unpublished data suggest that the response in the monkey is equivocal (15) . In both albino and pigmented rats, the most commonly affected sites are the white matter adjacent to the roof nuclei of the cerebellar folia, optic tracts but not the optic nerves, and the cerebral peduncle. Even in the most severely affected animals the lesions are focal in nature and the white matter is not diffusely affected.
The vacuolation is limited to the myelinated tracts and is the result of separation of the myelin sheath along the intraperiod line. There is no evidence of histological or ultrastructural change of the neuronal cell bodies and no increase of the extracellular space. Both myelinated and unmyelinated fibers appear normal even within the affected areas.
Histologically, the vacuolation is similar to that induced by triethyltin (1 , 1 l), hexachlorophene (1 3, 17) and isoniazid (2, 3). There are, however, clear differences between these compounds and vigabatrin. The myelinic vacuolation associated with vigabatrin is focal with a reasonably consistent pattern of response. It is localized to the brain, reversible upon cessation of exposure, and apparently nonprogressive (5, 9, 15). The three other compounds produce a diffuse vacuolation which also involves the spinal cord. Both isoniazid and hexachlorophene produce demyelination and also, to some extent, axonal degeneration, none of which was apparent in this study. Although it is not clear at this juncture whether the brain lesions described here for the rat will occur in man during anti-epileptic therapy, studies in more than 250 patients for as long as 3 years have not shown any evidence of neurotoxicity or untoward reactions that might be related to myelinic vacuolation (5).
